PATENT CLAIM ANALYSIS

Application Number: 16062320
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "487000"]

Abstract:
An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation of such compositions and using those compositions for the treatment of Chronic Myeloid Leukemia and other tumors such as head and neck cancer, prostate cancer and the like.

Claim (Index 3):
The formulation as claimed in  claim 1 , wherein NRC-AN-019 is in crystalline Form I, Form II, Form III or a combination thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 94.0
- Lexical Diversity: 1.34545
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14003445', '15200419', '14159679', '15328381', '15039442']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.715309535165249
- 35 USC 102 Novelty (BERT): 0.5344725442858008
- Combined Prediction Score: 0.6972258360773043
- Mean Citation Score: 261.61183600000004
- Max Citation Score: 310.02084
- Similarity Product: 165.2280039691615

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test